| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 原料药(元) | 663,463,946.02 | 1,297,701,085.15 | 667,437,847.40 |
| 制剂药销售(元) | 1,316,372,595.81 | 2,929,101,286.64 | 1,515,645,735.41 |
| 其他(元) | 1,872,771,584.58 | 3,275,752,537.44 | 1,985,432,892.38 |
| 营业成本(元) | |||
| 原料药(元) | 281,239,588.13 | 439,802,210.62 | 250,333,510.46 |
| 制剂药销售(元) | 506,335,651.54 | 1,176,996,571.88 | 592,013,863.24 |
| 其他(元) | 1,727,594,147.08 | 2,979,667,497.02 | 1,848,713,337.50 |
| 毛利(元) | |||
| 原料药(元) | 382,224,357.89 | 857,898,874.53 | 417,104,336.94 |
| 制剂药销售(元) | 810,036,944.27 | 1,752,104,714.76 | 923,631,872.17 |
| 其他(元) | 145,177,437.50 | 296,085,040.42 | 136,719,554.88 |
| 毛利率(%) | |||
| 原料药(%) | 57.61 | 66.11 | 62.49 |
| 制剂药销售(%) | 61.54 | 59.82 | 60.94 |
| 其他(%) | 7.75 | 9.04 | 6.89 |
| 收入构成(%) | |||
| 原料药(%) | 17.22 | 17.30 | 16.01 |
| 制剂药销售(%) | 34.17 | 39.04 | 36.36 |
| 其他(%) | 48.61 | 43.66 | 47.63 |
| 毛利构成(%) | |||
| 原料药(%) | 28.58 | 29.52 | 28.23 |
| 制剂药销售(%) | 60.57 | 60.29 | 62.52 |
| 其他(%) | 10.85 | 10.19 | 9.25 |